NCT04766567

Brief Summary

The present study aims to investigate whether there is a difference in short- and long-term complications in patients undergoing cesarean myomectomy (endometrial or serosal myomectomy) during cesarean section.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2021

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

February 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 23, 2021

Completed
Last Updated

February 23, 2021

Status Verified

February 1, 2021

Enrollment Period

7 months

First QC Date

February 1, 2021

Last Update Submit

February 21, 2021

Conditions

Keywords

Cesarean sectionCesarean myomectomy

Outcome Measures

Primary Outcomes (1)

  • Complications of cesarean myomectomy

    The difference in the rate of complications associated with the cesarean myomectomy (presence of adhesion formation, time to achieve pregnancy (fertility), morphology of the myomectomy scar, presence of uterine rupture and placental abnormalities) in patients undergoing endometrial myomectomy, serosal myomectomy, or not receiving myomectomy during cesarean section

    Post-cesarean 12 months

Study Arms (3)

Serosal myomectomy

EXPERIMENTAL

Patients with singleton pregnancy, who had serosal myomectomy during cesarean section

Procedure: Cesarean section with cesarean myomectomy (serosal)

Endometrial myomectomy

EXPERIMENTAL

Patients with singleton pregnancy, who had endometrial myomectomy during cesarean section

Procedure: Cesarean section with cesarean myomectomy (serosal)

Control group

PLACEBO COMPARATOR

Patients with singleton pregnancy, who did not have myomectomy during cesarean section

Procedure: Cesarean section without myomectomy

Interventions

Serosal or endometrial myomectomy performed during cesarean section

Also known as: Cesarean section with cesarean myomectomy (endometrial)
Endometrial myomectomySerosal myomectomy

Cesarean delivery without performing myoemctomy

Control group

Eligibility Criteria

Age18 Years - 49 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Participants should have singleton pregnancy delivered by cesarean section
  • Cesarean section technique should include: Transverse hysterotomy to enter the uterine cavity, single layer closure of the uterine wall, non-sutured visceral and parietal peritoneum
  • Myomectomy during cesarean section should include: only patients, who have undergone a single myomectomy and have been applied a single layer suture technique with the preservation of the pseudocapsule-for all cesarean myomectomy cases

You may not qualify if:

  • Patients having history of any malignancy
  • Patients with coagulation disorders
  • Patients with a history of previous intraabdominal surgery on reproductive organs
  • Patients with a history of endometriosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medicana Samsun Hospital

Samsun, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Cesarean SectionUterine Myomectomy

Intervention Hierarchy (Ancestors)

Delivery, ObstetricObstetric Surgical ProceduresSurgical Procedures, OperativeGynecologic Surgical ProceduresUrogenital Surgical Procedures

Study Officials

  • Oguz Guler, M.D.

    Bilge Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

February 1, 2021

First Posted

February 23, 2021

Study Start

June 15, 2020

Primary Completion

January 15, 2021

Study Completion

February 1, 2021

Last Updated

February 23, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations